approval
saveINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: BRISTOL-MYERS. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalMar 18, 2026 · 205d ago
- approvalINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalJul 30, 2024 · 801d ago
- approvalINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalMay 15, 2023 · 1243d ago
- approvalINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalDec 3, 2021 · 1771d ago
- approvalINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalNov 23, 2021 · 1781d ago
- approvalINREBIC (FEDRATINIB HYDROCHLORIDE) — FDA approvalAug 16, 2019 · 2611d ago
same company · ±60 days · 5
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalMay 23, 2025
- approval(hyaluronidase (recombinant, human) + nivolumab): OPDIVO QVANTIG (NIVOLUMAB) — FDA approvalMay 23, 2025
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalApr 11, 2025
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalApr 8, 2025
- approvalnivolumab: OPDIVO (NIVOLUMAB) — FDA approvalJul 1, 2025
comments(0)
5-min edit window · permanent after that